178 related articles for article (PubMed ID: 9806789)
1. Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells.
Simm A; Hoppe V; Karbach D; Leicht M; Fenn A; Hoppe J
Exp Cell Res; 1998 Nov; 244(2):379-93. PubMed ID: 9806789
[TBL] [Abstract][Full Text] [Related]
2. Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: involvement of the p70S6 kinase in the onset of protein and rRNA synthesis.
Leicht M; Simm A; Bertsch G; Hoppe J
Cell Growth Differ; 1996 Sep; 7(9):1199-209. PubMed ID: 8877101
[TBL] [Abstract][Full Text] [Related]
3. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
[TBL] [Abstract][Full Text] [Related]
4. Impairments in both p70 S6 kinase and extracellular signal-regulated kinase signaling pathways contribute to the decline in proliferative capacity of aged hepatocytes.
Liu Y; Gorospe M; Kokkonen GC; Boluyt MO; Younes A; Mock YD; Wang X; Roth GS; Holbrook NJ
Exp Cell Res; 1998 Apr; 240(1):40-8. PubMed ID: 9570919
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
7. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor.
Yu Y; Sato JD
J Cell Physiol; 1999 Feb; 178(2):235-46. PubMed ID: 10048588
[TBL] [Abstract][Full Text] [Related]
8. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
[TBL] [Abstract][Full Text] [Related]
9. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation.
Shah SA; Potter MW; Ricciardi R; Perugini RA; Callery MP
J Surg Res; 2001 May; 97(2):123-30. PubMed ID: 11341787
[TBL] [Abstract][Full Text] [Related]
10. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
Murakami-Mori K; Mori S; Nakamura S
J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
[TBL] [Abstract][Full Text] [Related]
11. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase.
Chung J; Grammer TC; Lemon KP; Kazlauskas A; Blenis J
Nature; 1994 Jul; 370(6484):71-5. PubMed ID: 8015612
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
Henry MK; Nimbalkar D; Hohl RJ; Quelle FW
Exp Cell Res; 2004 Sep; 299(1):257-66. PubMed ID: 15302592
[TBL] [Abstract][Full Text] [Related]
14. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
15. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms.
Somwar R; Sumitani S; Taha C; Sweeney G; Klip A
Am J Physiol; 1998 Oct; 275(4):E618-25. PubMed ID: 9755080
[TBL] [Abstract][Full Text] [Related]
16. Requirement of the serine-threonine kinase Akt for heat treatment-induced activation of p70 S6 kinase.
Kuroda S; Ogawa W; Kitamura T; Konishi H; Kikkawa U; Kasuga M
Biochem Biophys Res Commun; 1998 Aug; 249(3):781-5. PubMed ID: 9731213
[TBL] [Abstract][Full Text] [Related]
17. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling.
Rani CS; Wang F; Fuior E; Berger A; Wu J; Sturgill TW; Beitner-Johnson D; LeRoith D; Varticovski L; Spiegel S
J Biol Chem; 1997 Apr; 272(16):10777-83. PubMed ID: 9099730
[TBL] [Abstract][Full Text] [Related]
18. Activation of p70/p85 S6 kinase by a pathway independent of p21ras.
Ming XF; Burgering BM; Wennström S; Claesson-Welsh L; Heldin CH; Bos JL; Kozma SC; Thomas G
Nature; 1994 Sep; 371(6496):426-9. PubMed ID: 8090223
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
20. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
